Fig. 6From: Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case reportAfter two months of follow-up (and withdrawal of pembrolizumab) OCT showed no longer subretinal fluid in the right eye, though still a misalignment of the outer retinal layers. In the left eye there was still some residual fluid, however less than beforeBack to article page